Australia Ranked As Second Most Expensive Country For Clinical Trials; Medicines Australia Calls For Reform
This article was originally published in PharmAsia News
Executive Summary
A strong currency and cumbersome rules have contributed to Australia becoming the second-most expensive country for clinical trials, and neighboring countries are taking advantage.